5 results
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
own benefits and risks ... the hypoglycemia risk ... #pharmacology #pharmacotherapy ... #table #comparison ... medications #diabetes #endocrinology
Characteristics of Commonly Used Phosphate Binders 
Aluminum 
 - Potent and effective 
 - Useful for
Used Phosphate Binders ... salts - Lower risk ... #Phosphate #Binders ... #Table #Comparison ... #Pharmacology #
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... Januvia) - Once/day tablet ... associated with t risk ... DPP4 #Inhibitors #Pharmacology ... DM2 #diabetes #endocrinology
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
nonspecifically binds ... sodium intake; risk ... #medications #pharmacology ... #table #comparison ... #binders
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... Ozempic), or daily tablet ... outcomes in high risk ... effect) • May ↑ risk ... DM2 #diabetes #endocrinology